viewTHC Global Group Ltd

Full interview: THC Global Group granted GMP Licence for Southport cannabis facility

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA).

This milestone completes all licences required for THC Global to commence commercial manufacture of pharmaceutical medicinal cannabis.

Production at the facility on the Gold Coast began in early December.

The company also recently signed a supply agreement with MGC Pharmaceuticals Ltd for the supply of formulated medicinal cannabis products for Australian patients and the global export market.

READ: THC Global is all licensed up and ready to go: MST Access

Quick facts: THC Global Group Ltd

Price: 0.23 AUD

Market: ASX
Market Cap: $40.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...


THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.   "It's a significnat milestone ... we now are a farm-to-pharma process which...

on 06/12/2019

2 min read